Neuroscience News and Research

RSS

COPAXONE reduces loss of brain volume in patients with RRMS

Results from a five-year study of treatment-naïve patients with relapsing-remitting multiple sclerosis (RRMS) demonstrated that patients treated with COPAXONE (glatiramer acetate injection) showed significant reduced loss of brain volume compared to patients treated with other disease modifying therapies.

12 Oct 2011

CHOP, Albert Einstein College of Medicine to study genetics of conotruncal defects

The Eunice Kennedy Shriver National Institute of Child Health & Human Development, part of the National Institutes of Health, has awarded researchers at Albert Einstein College of Medicine of Yeshiva University and collaborators at the Children's Hospital of Philadelphia (CHOP) a five-year, $6.7 million grant to study the genetics of both rare and common congenital heart abnormalities known as conotruncal defects.

12 Oct 2011

FDA approves NDA for Edgemont's Fluoxetine 60 mg tablet

Edgemont Pharmaceuticals, LLC, a neuroscience focused company, today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Fluoxetine Tablets 60 mg.

12 Oct 2011

Paralyzed man moves robotic hand using mind

In a remarkable advance, a paralyzed man - Tim Hemmes - has managed to move a robot hand attached to his wheelchair only with the use of his mind. He was left paralyzed after a motorcycle accident. Moving a robot hand towards his girlfriend was a success for both the man and for the team of scientists at the University of Pittsburgh, who led and monitored the experiment.

11 Oct 2011

Aspirin desensitization procedure can benefit patients with sinusitis, asthma and AERD

Beth Moore can now keep up with her children. The suburban Philadelphia mother of two had suffered from allergies and chronic sinusitis since her teens. With age her symptoms became more severe, turning into bronchitis and eventually asthma, diminishing her ability to breathe and sapping her of her energy. The only complete relief came from aspirin; and the aspirin desensitization that allowed her to overcome her aspirin allergy and end her decades-long battle with sinusitis.

11 Oct 2011

Roche's gantenerumab removes amyloid plaques from the brain of patients with AD

Roche today announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer's disease. The study "Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab" is published today in the October issue of Archives in Neurology.

11 Oct 2011

Gantenerumab appears to reduce brain amyloid levels in patients with AD

Although it is a small study and more clinical trials are needed, treatment with the medication gantenerumab appeared to result in a reduction in brain amyloid levels in patients with Alzheimer disease, according to a report published Online First by Archives of Neurology, one of the JAMA/Archives journals.

11 Oct 2011

Leg-crossers more likely to have good recovery after severe stroke

People who are able to cross their legs soon after having a severe stroke appear to be more likely to have a good recovery compared to people who can't cross their legs.

11 Oct 2011

Our brain may filter out negativity to provide a rosier picture: Study

A new study shows that a reason why optimists retain a positive outlook even in the face of reality could be that the brain rejects bad news. The study published in Nature Neuroscience adds that in some people, anything negative is practically ignored - with them retaining a positive world view.

10 Oct 2011

Lack of sleep during adolescence could lead to more than dragging, foggy teens

An ongoing lack of sleep during adolescence could lead to more than dragging, foggy teens, a University of Wisconsin-Madison study suggests.

10 Oct 2011

BDNF methionine variation increases risk of suicidal behaviour

A new study from the Centre for Addiction and Mental Health has found evidence that a specific gene is linked to suicidal behaviour, adding to our knowledge of the many complex causes of suicide. This research may help doctors one day target the gene in prevention efforts.

10 Oct 2011

The paralyzed could walk again with a “prosthetic exoskeleton”

The team claims that they have cleared a hurdle to the construction of a prosthetic suit that will enable the paralyzed to walk, as well as restore their sense of touch. They are working towards the opening day of the 2014 World Cup soccer tournament in Brazil when they hope to send in a young quadriplegic striding out to playing fields to open the games.

9 Oct 2011

BDNF met variation gene linked to suicidal behaviour

7 Oct 2011

Study reveals neuronal networks behind self-control

Civilized human cohabitation requires us to respect elementary social norms. We guarantee compliance with these norms with our willingness to punish norm violations - often even at our own expense. This behavior goes against our own economic self-interest and requires us to control our egoistic impulses.

7 Oct 2011